Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing for crossover of two hazard functions using Gail and Simon's method.

Y H Joshua Chen1, G H Frank Liu

  • 1Clinical Biostatistics, Merck Research Laboratories, West Point, Pennsylvania 19486, USA. joshua_chen@merck.com

Journal of Biopharmaceutical Statistics
|May 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical inference following sample size adjustment based on the 50%-conditional-power principle.

Journal of biopharmaceutical statistics·2017
Same author

Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.

Clinical trials (London, England)·2015
Same author

A seamless phase IIB/III adaptive outcome trial: design rationale and implementation challenges.

Clinical trials (London, England)·2014
Same author

Testing superiority at interim analyses in a non-inferiority trial.

Statistics in medicine·2012
Same author

Some drop-the-loser designs for monitoring multiple doses.

Statistics in medicine·2010
Same author

On methods to utilize HIV-RNA data measured by two different PCR assays.

Journal of biopharmaceutical statistics·2008
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces new statistical tests to detect hazard function crossovers, crucial for evaluating long-term treatment effects and safety. These methods help determine if observed crossovers are statistically significant or due to chance.

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Clinical Trial Methodology

Background:

  • Hazard function crossovers, termed qualitative nonproportionality, complicate long-term treatment effect assessment.
  • Standard methods like Cox proportional hazards models may be inappropriate when hazard functions cross.
  • Visual inspection of hazard functions can suggest crossovers, but statistical validation is needed.

Purpose of the Study:

  • To propose and evaluate statistical tests for detecting crossovers in hazard functions.
  • To provide methods for assessing the significance of observed hazard function crossovers.
  • To aid in the long-term management of treatment safety and efficacy.

Main Methods:

  • Dividing the follow-up period into nonoverlapping time intervals.

Related Experiment Videos

  • Calculating weighted linear rank statistics (e.g., logrank, generalized Wilcoxon) within each interval.
  • Applying qualitative tests of treatment-subset interactions, specifically the Gail and Simon likelihood ratio test.

    • Main Results:

    • The proposed tests treat time intervals as 'patient subsets' for interaction analysis.
    • Statistics calculated from intervals are asymptotically independent and normally distributed.
    • Simulations and examples illustrate the application and validity of the proposed test procedures.

    Conclusions:

    • The developed tests offer a robust approach to formally assess hazard function crossovers.
    • Accurate detection of crossovers is vital for reliable interpretation of long-term treatment benefits and risks.
    • These methods enhance the statistical toolkit for analyzing time-to-event data in clinical research.